ATE109007T1 - Zellfreies marekskrankheitvirus-vakzin. - Google Patents

Zellfreies marekskrankheitvirus-vakzin.

Info

Publication number
ATE109007T1
ATE109007T1 AT91203365T AT91203365T ATE109007T1 AT E109007 T1 ATE109007 T1 AT E109007T1 AT 91203365 T AT91203365 T AT 91203365T AT 91203365 T AT91203365 T AT 91203365T AT E109007 T1 ATE109007 T1 AT E109007T1
Authority
AT
Austria
Prior art keywords
disease virus
cell
marek
virus vaccine
vaccine
Prior art date
Application number
AT91203365T
Other languages
English (en)
Inventor
William Baxendale
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE109007(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE109007T1 publication Critical patent/ATE109007T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT91203365T 1990-12-24 1991-12-20 Zellfreies marekskrankheitvirus-vakzin. ATE109007T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (1)

Publication Number Publication Date
ATE109007T1 true ATE109007T1 (de) 1994-08-15

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91203365T ATE109007T1 (de) 1990-12-24 1991-12-20 Zellfreies marekskrankheitvirus-vakzin.

Country Status (17)

Country Link
US (1) US5378467A (de)
EP (1) EP0496135B1 (de)
JP (1) JP3410744B2 (de)
KR (1) KR100187317B1 (de)
CN (1) CN1034554C (de)
AT (1) ATE109007T1 (de)
CA (1) CA2058386C (de)
DE (1) DE69103130T2 (de)
DK (1) DK0496135T3 (de)
DZ (1) DZ1550A1 (de)
ES (1) ES2061165T3 (de)
HU (2) HUT62200A (de)
IL (1) IL100386A (de)
MX (1) MX9102757A (de)
NZ (1) NZ241122A (de)
SA (1) SA92120430B1 (de)
ZA (1) ZA9110022B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
EP0703294A1 (de) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Virusimpfstoff gegen Mareksche Krankheit
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
DK2384761T3 (da) 2010-05-07 2013-12-09 Deutsches Krebsforsch Modificeret gnaverparvovirus, som er i stand til formering og spredning i humane gliomer
EP3727431A1 (de) 2017-12-20 2020-10-28 Intervet International B.V. Verbessertes verdünnungsmittel für zellassoziierten alphaherpesvirus-impfstoff

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
HU210344A9 (en) 1995-04-28
CA2058386A1 (en) 1992-06-25
EP0496135B1 (de) 1994-07-27
NZ241122A (en) 1992-10-28
EP0496135A3 (de) 1992-08-05
DK0496135T3 (da) 1994-11-28
KR920011520A (ko) 1992-07-24
CN1064409A (zh) 1992-09-16
MX9102757A (es) 1992-07-01
ES2061165T3 (es) 1994-12-01
CA2058386C (en) 2003-02-11
KR100187317B1 (ko) 1999-05-01
DZ1550A1 (fr) 2002-02-17
IL100386A (en) 1995-07-31
DE69103130T2 (de) 1994-12-01
JPH04295433A (ja) 1992-10-20
JP3410744B2 (ja) 2003-05-26
ZA9110022B (en) 1992-10-28
US5378467A (en) 1995-01-03
HUT62200A (en) 1993-04-28
SA92120430B1 (ar) 2004-05-31
DE69103130D1 (de) 1994-09-01
HU914111D0 (en) 1992-03-30
EP0496135A2 (de) 1992-07-29
CN1034554C (zh) 1997-04-16
IL100386A0 (en) 1992-09-06

Similar Documents

Publication Publication Date Title
DE69016956T2 (de) Rekombinantes Truthahn-Herpesvirus und davon abgeleiteter Lebendimpfstoffvektor.
BR9102672A (pt) Composicao para exterminar microorganismos, composicao para exterminar virus envelopados, processo para exterminar microorganismos em ou sobre um hospedeiro e processo para exterminar virus envelopados em um ser humano ou animal de sangue quente, hospedeiro
DE3789399D1 (de) Herstellung von Vakkzinen gegen Hepatitis B-Virus.
MY103575A (en) Cannie coronavirus vaccine
DK0496135T3 (da) Cellefri Mareks sygdomsvirus-vaccine
IE780360L (en) Vaccine against "egg drop disease".
FI890116A (fi) Icke-reverterande rna-virus.
ATE86119T1 (de) Lebendvaccine fuer ansteckungskrankheiten von kueken.
WO1994000586A3 (fr) Mutants et vaccins du virus de la rhinotracheite infectieuse bovine
ATE59778T1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
DK1087014T3 (da) Svinepestvirusvaccine og -diagnostik
MX9602256A (es) Vacuna contra la enfermedad de marek.
NZ228232A (en) Live combined vaccine comprising at least one live infectious bronchitis virus and at least one other virus infectious to poultry
ES515472A0 (es) Procedimiento para proteger anfitriones susceptibles de infeccion de hepatitis.
DE59209310D1 (de) Impfstoffe auf Basis geänderter Boviner Herpesviren Typ 1
DE2965191D1 (en) Herpes virus vaccine and its preparation
ATE310078T1 (de) Hühner-anäemie-virus mit geringer pathogenität
ES2084587T3 (es) Arn virus no revertientes.
NO884921L (no) Fremgangsmaate for fremstilling av valpesyke-vaksine.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee
RZN Patent revoked